Postcovid cardio-metabolic disorders in residents of Yakutsk
https://doi.org/10.25789/YMJ.2022.79.16
Abstract
A pilot single-stage study of residents of Yakutsk, attached to the YSC CMP Clinic, with a history of new coronavirus infection COVID-19 in the period from March to December 2020 (1st and 2nd waves of the pandemic) was conducted. 2 groups of 80 people from 30 to 59 years old were formed, which were divided according to the time of infection with COVID-19. The 1st group included patients with a postcovid period from 3 to 6 months, in the 2nd from 7 to 11 months. The analysis revealed a high frequency of cardiometabolic disorders, in particular hypertension, obesity and metabolic syndrome. Men had a more severe course of infection, both in the first and in the second wave of the pandemic. The relationship between blood pressure, body mass index, waist circumference and blood triglyceride levels with the severity of the disease is presented.
About the Authors
S. I. Sofronova
Yakut Scientific Centre of Complex Medical Problems
Russian Federation
Russian Federation
Sofronova Sargylana Ivanovna - PhD, leading researcher
A. N. Romanova
Yakut Scientific Centre of Complex Medical Problems
Russian Federation
Russian Federation
Romanova Anna Nikolaevna - MD, director
V. M. Nikolaev
Yakut Scientific Centre of Complex Medical Problems
Russian Federation
Russian Federation
Nikolaev Vyacheslav Mikhailovich - PhD, researcher
L. D. Olesova
Yakut Scientific Centre of Complex Medical Problems
Russian Federation
Russian Federation
Olesova Lubov Dygynovna - PhD, researcher
References
1. Analysis of the epidemiological situation on COVID-19: the second wave / T.E. Popova, O.G. Tikhonova, A.N. Romanova [et al.]. Yakut medical journal. – 2021. – No.1. – P. 61-64. Doi:10/25789/YMJ.2021.73.17
2. Cardiovascular pathology and COVID-19 in residents of Yakutsk / S.I. Sofronova, V.M. Nikolaev, I.V. Kononova [et al.]. Yakut medical journal. – 2022. – No. 1. – P. 90-93. Doi:10.25789/YMJ.2022.77.23
3. Clinical features of the post-COVID period. Results of the international registry "Analysis of the dynamics of comorbid diseases in patients who have undergone SARS-CoV-2 infection (SARS-CoV-2 ACTIVE)". Preliminary data (6 months of follow-up) / Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G. [et al.] // Rossijskij kardiologicheskij zhurnal. 2021; 10: 86-98. (In Russ.). Doi: 10/15829/1560-4071-2021-4708
4. International registry “Analysis of the dynamics of comorbid diseases in patients who have undergone SARS-CoV-2 infection (SARSCoV-2 ACTIVE)”: analysis of 1000 patients / G.P. Arutyunov, E.I. Tarlovskaya, A.G. Arutyunov [et al.]. Russian cardiologic journal. – 2020. – No. 11(25). – P. 98-107. doi:10.15829/1560-4071-2020-4165
5. International register “Dynamics analysis of comorbidities in SARS-COV-2 survivors” (AKTIV SARS-COV-2): Analysis of predictors of short-term adverse outcomes in COVID-19 / G.P. Arutyunov, E.I. Tarlovskaya, A.G. Arutyunov [et al.]. Russian cardiologic journal. – 2021. – No. 4(26). – P. 116-131. doi:10.15829/1560-4071-2021-4470
6. National clinical guidelines for the treatment of morbid obesity in adults. 3rd revision / [I.I. Dedov, G.A. Melnichenko, M.V. Shestakova [et al]. // Obesity and metabolism. - 2018; - 15(1). – P. 53-70.
7. Bae S, Kim S R, Kim M.-N, et al. Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID 19 according to age: a systematic review and meta-analysis. Heart 2021; 107(5): 373–380, https://doi.org/10.1136/heartjnl2020–317901
8. Chu Y, Yang J, Shi J, et al. Obesity is associated with increased severity of disease in COVID-19 pneumonia: a systematic review and meta-analysis. Eur J Med Res. 2020 Dec 2;25(1):64. doi: 10.1186/s40001-020-00464-9
9. Denson JL, Gillet AS, Zu Y, et al. Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19 //JAMA Netw Open. 2021 Dec 1;4(12):e2140568. doi: 10.1001/jamanetworkopen.2021.40568
10. Giorgi A D, Fabbian F, Greco S, et al. Prediction of in-hospital mortality of patients with SARS-CoV 2 infection by comorbidity indexes: an Italian internal medicine single center study. Eur Rev Med Pharmacol Sci 2020; 24(19): 10258–10266, https://doi.org/10.26355/eurrev_202010_23250.
11. Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2004; 89(6): 2595–600. https://doi.org/10.1210/jc.2004–0372.
12. Hidekatsu Y. Metabolic Syndrome and COVID-19 // Cardiol Res. 2020;11(6):360-365. https://doi.org/10.14740/cr1181
13. Kočar E, Rezen T, Rožman D. Cholesterol, lipoproteins, and COVID 19: basic concepts and clinical applications. Biochim Biophys Acta Mol Cell Biol Lipids 2021; 1866(2): 158849, https://doi.org/10.1016/j.bbalip.2020.158849
14. Manent JR, Jané BA, Cortés PS, et al. Impact of COVID-19 Lockdown on Anthropometric Variables, Blood Pressure, and Glucose and Lipid Profile in Healthy Adults: A before and after Pandemic Lockdown Longitudinal Study // Nutrients. 2022 Mar 15;14(6):1237. doi: 10.3390/nu14061237.
15. Petrov AN, Welford M, Golosov N.et al. The "second wave" of the COVID-19 pandemic in the Arctic: regional and temporal dynamics // Int J Circumpolar Health. 2021 Dec;80(1):1925446. doi: 10.1080/22423982.2021.1925446.
16. Pranata R, Lim MA, Yonas E, et al. Body mass index and outcome in patients with COVID-19: A dose-response meta-analysis / Diabetes Metab. 2021 Mar;47(2):101178. doi: 10.1016/j.diabet.2020.07.005
17. Roncon L, Zuin M, Rigatelli G, Zuliani G. Diabetic patients with COVID 19 infection are at higher risk of ICU admission and poor short-term outcome. J Clin Virol 2020; 127: 104354, https:// doi.org/10.1016/j.jcv.2020.104354.
18. Shukla D, Bhadoria S, Bansal M, Changulani R. Evolution of the pandemic: Analysis of demographic characteristics of COVID-19-infected patients during its two waves in Gwalior district of central India // J Family Med Prim Care. 2022 Apr;11(4):1314-1321. doi: 10.4103/jfmpc.jfmpc_1189_21.
19. Surma S, Banach M, Lewek J. COVID 19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV 2 infection. Lipids Health Dis 2021; 20(1): 141, https://doi.org/10.1186/s12944–021–01563–0.
20. Wang J, Zhu L, Liu L, et al. Clinical features and prognosis of COVID 19 patients with metabolic syndrome: a multicenter, retrospective study. Med Clin (Barc) 2021; S0025– 7753(21)00320–1, https://doi.org/10.1016/j.medcli.2021.05.014.
21. Williams B, Mancia G, Spierin W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) // European Heart Journal, Volume 39, Issue 33, 01 September 2018, Pages 3021–3104, https://doi.org/10.1093/eurheartj/ehy339
22. Yang J., Hu J., Zhu C. Obesity aggravates COVID 19: a systematic review and meta-analysis. J Med Virol 2020; 93(1): 257–261, https://doi.org/10.1002/jmv.26237.
23. Zuin M, Rigatelli G, Zuliani G, et al. Arterial hypertension and risk of death in patients with COVID 19 infection: systematic review and meta-analysis. J Infect 2020; 81(1): e84 e86, https://doi.org/10.1016/j.jinf.2020.03.059.
Review
For citations:
Sofronova S.I., Romanova A.N., Nikolaev V.M., Olesova L.D. Postcovid cardio-metabolic disorders in residents of Yakutsk. Yakut Medical Journal. 2022;(3):61-65. https://doi.org/10.25789/YMJ.2022.79.16
Views:
19
Email this article 